医学
嗜酸性食管炎
CD11c公司
嗜酸性粒细胞增多症
免疫系统
免疫学
FOXP3型
过敏性炎症
嗜酸性粒细胞
树突状细胞
淋巴
嗜酸性粒细胞趋化因子
炎症
内科学
病理
疾病
生物
哮喘
趋化因子
表型
基因
生物化学
作者
Flávia Márcia de Castro e Silva,Érick Esteves de Oliveira,Marcilene Gomes Evangelista Ambrósio,Marina Caçador Ayupe,Viviane Passos de Souza,Jacy Gameiro,Danièle Reis,Marco Antônio Machado,Gilson Costa Macedo,Joërg Mattes,Ana Paula Ferreira
摘要
Eosinophilic oesophagitis (EoE) is an emergent chronic immune-mediated disease of the oesophagus, which affects both children and adults. It is clinically characterized by dysphagia, food impaction and oesophageal eosinophilia. Epidemiological studies indicate that obesity can worsen allergic symptoms; however, its effect on EoE immunopathological response has not been evaluated yet. This study aimed to assess the effect of obesity on allergic inflammation and T helper-2 profile in an EoE experimental model.Obesity was induced by high-fat feeding. After 7 weeks of diet, male BALB/c mice were subcutaneously sensitized and orally challenged with OVA.Obesity itself induced a significant mast cell and eosinophil accumulation in the oesophagus, trachea, gut and lung. After allergy induction, this number was higher, when compared to lean-allergic mice. Moreover, obese-allergic mice showed higher remodelling area, in the oesophagus, associated with higher IL-5 and TSLP mRNA expression. In contrast, FoxP3 and IL-10 were less expressed in comparison with lean-allergic mice. In addition, the amount of CD11c+ MHCII+ PDL1+ dendritic cells was reduced, while the number of CD11c+ MHCII+ CD80+ DCs and CD3+ CD4+ GATA3+ IL-4+ cells was increased in obese-allergic mice in the spleen and lymph nodes when compared to lean-allergic mice.Obesity aggravated the immune histopathological characteristics in the EoE experimental model, which was associated with the reduction in the regulatory profile, and the increased inflammatory cells influx, related to the TH 2 profile. Altogether, the data provide new knowledge about obesity as a risk factor, worsening EoE symptoms, and contribute for future treatment strategies for this specific profile.
科研通智能强力驱动
Strongly Powered by AbleSci AI